Article citationsMore>>

T. P. Hughes, S. Branford, D. L. White, J. Reynolds, R. Koelmeyer, J. F. Seymour, K. Taylor, C. Arthur, A. Schwarer, J. Morton, J. Cooney, M. F. Leahy, P. Rowlings, J. Catalano, M. Hertzberg, R. Filshie, A. K. Mills, K. Fay, S. Durrant, H. Januszewicz, D. Joske, C. Underhill, S. Dunkley, K. Lynch and A. Grigg, “Australasian Leukaemia and Lymphoma Group. Impact of Early Dose Intensity on Cytogenetic and Molecular Responses in Chronic-Phase CML Patients Receiving 600 mg/day of Imatinib as Initial Therapy,” Blood, Vol. 112, No. 10, 2008, pp. 3965-3973. doi:10.1182/blood-2008-06-161737

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top